Fixed dose comparison of escitalopram to an active comparator in severely depressed patients

Trial Profile

Fixed dose comparison of escitalopram to an active comparator in severely depressed patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs Duloxetine; Escitalopram
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors Forest Laboratories
  • Most Recent Events

    • 04 Jan 2008 Status changed from in progress to completed.
    • 15 Aug 2007 Status changed from recruiting to in progress.
    • 19 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top